Phage resistance formation and fitness costs of hypervirulent Klebsiella pneumoniae mediated by K2 capsule-specific phage and the corresponding mechanisms
Формирование фагорезистентности и фитнес-издержки гипервирулентной Klebsiella pneumoniae, опосредованные фагом, специфичным к капсуле K2, и соответствующие механизмы
2023-07-19
SCID: 54.1/zv3qq2xh
Discuss with AI
K2 capsule-specific phageKlebsiella pneumoniaecapsule biosynthesisfitness costsphage resistance
Figures from the paper
Abstract (AI)
Introduction Phage is promising for the treatment of hypervirulent Klebsiella pneumoniae (hvKP) infections. Although phage resistance seems inevitable, we found that there still was optimization space in phage therapy for hvKP infection. Methods The clinical isolate K. pneumoniae FK1979 was used to recover the lysis phage ΦFK1979 from hospital sewage. Phage-resistant bacteria were obtained on LB agar and used to isolate phages from sewage. The plaque assay, transmission electron microscopy (TEM), multiplicity of infection test, one-step growth curve assay, and genome analysis were performed to characterize the phages. Colony morphology, precipitation test and scanning electron microscope were used to characterize the bacteria. The absorption test, spot test and efficiency of plating (EOP) assay were used to identify the sensitivity of bacteria to phages. Whole genome sequencing (WGS) was used to identify gene mutations of phage-resistant bacteria. The gene expression levels were detected by RT-qPCR. Genes knockout and complementation of the mutant genes were performed. The change of capsules was detected by capsule quantification and TEM. The growth kinetics, serum resistance, biofilm formation, adhesion and invasion to A549 and RAW 264.7 cells, as well as G. mellonella and mice infection models, were used to evaluate the fitness and virulence of bacteria. Results and discussion Here, we demonstrated that K2 capsule type sequence type 86 hvKP FK1979, one of the main pandemic lineages of hvKP with thick capsule, rapidly developed resistance to a K2-specific lysis phage ΦFK1979 which was well-studied in this work to possess polysaccharide depolymerase. The phage-resistant mutants showed a marked decrease in capsule expression. WGS revealed single nucleotide polymorphism (SNP) in genes encoding RfaH, galU, sugar glycosyltransferase, and polysaccharide deacetylase family protein in the mutants. RfaH and galU were further identified as being required for capsule production and phage sensitivity. Expressions of genes involved in the biosynthesis or regulation of capsule and/or lipopolysaccharide significantly decreased in the mutants. Despite the rapid and frequent development of phage resistance being a disadvantage, the attenuation of virulence and fitness in vitro and in vivo indicated that phage-resistant mutants of hvKP were more susceptible to the immunity system. Interestingly, the newly isolated phages targeting mutants changed significantly in their plaque and virus particle morphology. Their genomes were much larger than and significantly different from that of ΦFK1979. They possessed much more functional proteins and strikingly broader host spectrums than ΦFK1979. Our study suggests that K2-specific phage has the potential to function as an antivirulence agent, or a part of phage cocktails combined with phages targeting phage-resistant bacteria, against hvKP-relevant infections.
Key Findings
1
Functional experiments established that rfaH and galU are required for capsule production and contribute to phage susceptibility.
2
K2 capsule-type ST86 hypervirulent Klebsiella pneumoniae rapidly developed resistance to the K2-specific depolymerase-producing phage ΦFK1979.
3
Phage-resistant mutants exhibited markedly reduced capsule expression compared with the parental strain.
4
The study indicates that phage resistance may impose bacterial fitness or virulence costs, supporting optimization of phage therapy through exploiting resistance-associated capsule loss.
5
Whole-genome sequencing identified mutations in rfaH, galU, sugar glycosyltransferase, and polysaccharide deacetylase family genes in resistant mutants.
Research Object
K2 capsule-type sequence type 86 hypervirulent Klebsiella pneumoniae FK1979 and its resistance mutants exposed to the K2 capsule-specific lytic phage ΦFK1979
Research Subject
Phage-resistance formation, capsule reduction, fitness and virulence costs, and the genetic mechanisms underlying these changes
Publication Details
Publication Date
2023-07-19
Journal
Publisher
ISSN
Cited by
61
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process2017
Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii2022
Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase2021
The Mutation in wbaP cps Gene Cluster Selected by Phage-Borne Depolymerase Abolishes Capsule Production and Diminishes the Virulence of Klebsiella pneumoniae2021
Novel Phage-Derived Depolymerase with Activity against Proteus mirabilis Biofilms2021